The European Medicines Agency Accepted The Marketing Authorization Application For Rocket Pharmaceuticals' RP-l102 For Fanconi Anemia
欧洲药品管理局接受了Rocket Pharmicals针对范可尼贫血的RP-L102的上市许可申请
The European Medicines Agency Accepted The Marketing Authorization Application For Rocket Pharmaceuticals' RP-l102 For Fanconi Anemia
欧洲药品管理局接受了Rocket Pharmicals针对范可尼贫血的RP-L102的上市许可申请
使用浏览器的分享功能,分享给你的好友吧